Literature DB >> 31394382

Doxycycline inhibits NAcht Leucine-rich repeat Protein 3 inflammasome activation and interleukin-1β production induced by Porphyromonas gingivalis-lipopolysaccharide and adenosine triphosphate in human gingival fibroblasts.

Shuo Xu1, Qihui Zhou2, Chun Fan3, Hongmei Zhao4, Yanwen Wang5, Xiaohui Qiu1, Kai Yang1, Qiuxia Ji6.   

Abstract

OBJECTIVE: To investigate the effect of adenosine triphosphate (ATP) on inflammasome activation by Porphyromonas gingivalis-lipopolysaccharide (P. gingivalis-LPS) stimulation and the anti-inflammatory eff ;ect of doxycycline (Dox) in human gingival fibroblasts (HGFs).
DESIGN: The optimal concentration of P. gingivalis-LPS (1.0 μg/mL) for cellular viability was determined by observing cell morphology and measuring the amount of formazan and the expression of pro-caspase-1. The expression of genes and proteins related to the NAcht Leucine-rich repeat Protein 3 (NLRP3) inflammasome, including NLRP3, apoptosis-associated speck-like protein containing CARD (ASC), caspase-1 and its activated forms, and the inflammatory factor interleukin-1β (IL-1β) and its activated forms were measured.
RESULTS: The NLRP3 inflammasome (i.e., NLRP3, ASC, caspase-1) was not affected by stimulation with P. gingivalis-LPS or ATP. However, a combination of P. gingivalis-LPS and ATP significantly enhanced inflammasome activation and IL-1β production at the gene and protein levels as measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot, respectively. Furthermore, doxycycline addition markedly inhibited inflammasome activation and IL-1β production induced by a combination of P. gingivalis-LPS and ATP.
CONCLUSIONS: LPS, ATP, and doxycycline play critical roles in regulating host immune responses. This evidence provides guidance for the application of tetracycline drugs for the clinical treatment of periodontal disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine triphosphate; Doxycycline; IL-1β; NLRP3 inflammasome; P. gingivalis-LPS; Periodontitis

Mesh:

Substances:

Year:  2019        PMID: 31394382     DOI: 10.1016/j.archoralbio.2019.104514

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  5 in total

1.  Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway.

Authors:  Shanya Jiang; Nicole M Maphis; Jessica Binder; Devon Chisholm; Lea Weston; Walter Duran; Crina Peterson; Amber Zimmerman; Michael A Mandell; Stephen D Jett; Eileen Bigio; Changiz Geula; Nikolaos Mellios; Jason P Weick; Gary A Rosenberg; Eicke Latz; Michael T Heneka; Kiran Bhaskar
Journal:  Cell Rep       Date:  2021-09-21       Impact factor: 9.995

2.  Different expression patterns of inflammatory cytokines induced by lipopolysaccharides from Escherichia coli or Porphyromonas gingivalis in human dental pulp stem cells.

Authors:  Chunhua Lan; Shuai Chen; Shan Jiang; Huaxiang Lei; Zhiyu Cai; Xiaojing Huang
Journal:  BMC Oral Health       Date:  2022-04-12       Impact factor: 2.757

Review 3.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

4.  SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.

Authors:  Huanzhou Xu; Ibukun A Akinyemi; Siddhi A Chitre; Julia C Loeb; John A Lednicky; Michael T McIntosh; Sumita Bhaduri-McIntosh
Journal:  Virology       Date:  2022-01-17       Impact factor: 3.616

5.  Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation.

Authors:  Mohammad Alsaadi; Gulcin Tezcan; Ekaterina E Garanina; Shaimaa Hamza; Alan McIntyre; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Pharmaceuticals (Basel)       Date:  2021-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.